| Descriptor English: | Didanosine | ||||||
| Descriptor Spanish: | Didanosina 
 | ||||||
| Descriptor Portuguese: | Didanosina | ||||||
| Descriptor French: | Didéoxyinosine | ||||||
| Entry term(s): | 2',3' Dideoxyinosine 2',3'-Dideoxyinosine Dideoxyinosine NSC 612049 NSC-612049 NSC612049 Videx ddI (Antiviral) | ||||||
| Tree number(s): | D03.633.100.759.590.616.130 D13.570.230.500.090 D13.570.583.616.130 D13.570.800.573.130 | ||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D016049 | ||||||
| Scope note: | A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. | ||||||
| Allowable Qualifiers: | AA                                                            analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine | ||||||
| Pharm Action: | Antimetabolites Reverse Transcriptase Inhibitors Anti-HIV Agents | ||||||
| Registry Number: | K3GDH6OH08 | ||||||
| CAS Type 1 Name: | Inosine, 2',3'-dideoxy- | ||||||
| Previous Indexing: | Dideoxynucleosides (1989) Inosine/analogs & derivatives (1987-1989) | ||||||
| Public MeSH Note: | 92; was DIDEOXYINOSINE 1990-91 | ||||||
| Online Note: | use DIDANOSINE to search DIDEOXYINOSINE 1990-91 | ||||||
| History Note: | 92; was DIDEOXYINOSINE 1990-91 | ||||||
| DeCS ID: | 30328 | ||||||
| Unique ID: | D016049 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1990/01/01 | ||||||
| Date of Entry: | 1989/07/14 | ||||||
| Revision Date: | 2017/05/24 | 
- 
                                    - 
                                        CHEMICALS AND DRUGS
 
 Heterocyclic Compounds [D03]Heterocyclic Compounds
|  | 
                        
                                                                    
                        Didanosine                                            
                                        - Preferred                                        
                                                                
                                
                        
                        
                        
                                                                    
                        Videx                                            
                                        - Narrower                                        
                                                                
                                
                                                                    
                        NSC-612049                                            
                                        - Narrower                                        
                                                                
                                
                        
                        
                    
                    
                
                | Concept UI | M0024535 | 
| Scope note | A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. Didanosine is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase; ddI is then metabolized to dideoxyadenosine triphosphate, its putative active metabolite. | 
| Preferred term | Didanosine | 
| Entry term(s) | 2',3' Dideoxyinosine 2',3'-Dideoxyinosine Dideoxyinosine ddI (Antiviral) | 
| Concept UI | M0024536 | 
| Preferred term | Videx | 
| Concept UI | M0328965 | 
| Preferred term | NSC-612049 | 
| Entry term(s) | NSC 612049 NSC612049 | 
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey